Celltrion secures new drug manufacturing partner in US - (The Korea Herald via NewsPoints Desk)

  • Celltrion has selected Baxter BioPharma Solutions as its manufacturing partner for Remsima in the US, The Korea Herald reported Friday.

  • Under the agreement, Baxter Biopharma Solutions will manufacture Remsima in the finished drug form.

  • "With the latest agreement, Celltrion has secured a local drug producer in the US, the world's biggest biopharmaceutical market," a Celltrion official commented, adding "the firm expects to meet local demand in a more flexible manner."

  • Remsima is a biosimilar of Johnson & Johnson's Remicade.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.

Reference Articles